Axogen CFO exercises options, sells 1,051 shares
Axogen, Inc. CFO Lindsey Marie Hartley reported an option-related share transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Axogen, Inc. CFO Lindsey Marie Hartley reported an option-related share transaction. On May 7, 2026, she exercised employee stock options to acquire a total of 5,463 shares of common stock at exercise prices of $8.20 and $8.27 per share, and sold 1,051 shares in open-market transactions at $43.67 per share. The options exercised were or will be fully vested under schedules that reach full vesting in March 2026 and March 2027, reflecting routine compensation-related activity.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Hartley Lindsey Marie
Role
CFO
Sold
1,051 shs ($46K)
Approx. gross sale proceeds
$46K
Approx. exercise cost
$45K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to purchase) | 2,500 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to purchase) | 2,963 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,500 | $8.20 | $21K |
| Sale | Common Stock | 478 | $43.67 | $21K |
| Exercise | Common Stock | 2,963 | $8.27 | $25K |
| Sale | Common Stock | 573 | $43.67 | $25K |
Holdings After Transaction:
Employee Stock Option (right to purchase) — 0 contracts (Direct);
Common Stock — 65,146 shares (Direct)
Footnotes (2)
- F1. All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on March 16, 2026.
- F2. All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
Key Figures
Shares sold: 1,051 shares
Sale price: $43.67/share
Options exercised: 5,463 shares
+4 more
7 metrics
Shares sold
1,051 shares
Common stock sold in open market on May 7, 2026
Sale price
$43.67/share
Price for common stock sales on May 7, 2026
Options exercised
5,463 shares
Total underlying common shares from option exercises
Option strike price 1
$8.27/share
Exercise price for 2,963-share employee stock option
Option strike price 2
$8.20/share
Exercise price for 2,500-share employee stock option
Full vesting date grant 1
March 16, 2026
Date all shares under one option became fully vested
Full vesting date grant 2
March 16, 2027
Scheduled date remaining option grant becomes fully vested
Key Terms
Employee Stock Option (right to purchase), derivative security, open-market sale, vesting schedule, +1 more
5 terms
Employee Stock Option (right to purchase) financial
"security_title: "Employee Stock Option (right to purchase)""
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
vesting schedule financial
"based upon a vesting schedule whereby 50% of the aggregate shares vested"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
fully vested financial
"All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Axogen (AXGN) CFO Lindsey Marie Hartley report in this Form 4?
Axogen CFO Lindsey Marie Hartley reported exercising employee stock options and selling some common shares. She acquired 5,463 shares through option exercises and sold 1,051 shares in open-market transactions, all on May 7, 2026, as part of routine equity compensation activity.
How many Axogen (AXGN) stock options did the CFO exercise and at what strike prices?
She exercised options covering a total of 5,463 shares of Axogen common stock. The underlying employee stock options had exercise prices of $8.20 and $8.27 per share, reflecting previously granted equity awards that were used to acquire additional common shares.
Were the Axogen (AXGN) options exercised by the CFO fully vested?
One option grant was already fully vested as of March 16, 2026. Another grant will be fully vested on March 16, 2027, following a schedule where 50% vested in March 2025 and an additional 12.5% vests every six months thereafter.
Does this Axogen (AXGN) Form 4 show any remaining stock options for the CFO?
The filing records option exercises for two employee stock option grants tied to 5,463 underlying shares and shows no remaining balance for those specific options. The derivative section reflects zero remaining shares for these grants after exercise, indicating those particular awards were fully used.
What type of transactions are reported in this Axogen (AXGN) insider filing?
The Form 4 reports a mix of derivative and non-derivative transactions. It includes option exercises classified as derivative exercises or conversions, and open-market sales of common stock, giving a combined picture of compensation-related activity and partial share dispositions by the CFO.
AI-generated analysis. How Rhea-AI works. Not financial advice.
